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TNRD detector) shown in the figure. The difference found in 
TNRD signal in 60Co and 6 MV (table) is justified by the higher 
response observed for the 14Si at low energies, taking into 
account that measurements are always performed in a 
peripheral area where scattering is dominant and thus mean 
energy lower. 
 
Figure. Logarithmic representation of the μen/ρ coefficient 
for 14Si in the range of 0-20 MeV, data extracted from: 
http://physics.nist.gov/PhysRefData/XrayMassCoef/ElemTab
/z14.html. 
Table. (See text) 
 
 
Conclusions: TNRD neutron detector has shown to be 
sensitive to photon dose rates even at low values (0.15-4 
cGy/min). Different behaviour has been noticed for 60Co and 
6 MV photon energies. Nevertheless, similar TNRD response to 
6 and 15 MV photons could be expected. In consequence, in 
order to reasonably avoid photon presence in peripheral 
neutron estimations, the subtraction of 6 MV signal to the 15 
MV one (under the same irradiation conditions) could be a 
good approximation. Further measurements and MC 
simulations, should be necessary to ensure this proposal for 
different linac energies. 
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Purpose/Objective: To study the dosimetric properties of 
TLD2000 thermoluminescent dosimeter (TLD), including 
repeatability, linearity of dose response, energy response and 
dose rate effect. 
Materials and Methods: 1300 TLD2000 TLDs were read out 
after exposure to a dose of 1 mGy of 65 keV x-ray, then were 
sorted out to have the same sensitivity within ±3.0%. TLDs 
were irradiated to a dose of 120 MU using 6 MV x-ray then 
irradiated to the same dose after 24 h. TLDs were irradiated 
by two 125I seeds with the same activity for 24 h, and the 
interval time was 24 h, to study the repeatability of TLDs for 
6 MV x-ray and 125I seed. TLDs were irradiated to different 
doses using 137Cs (662 keVγ-ray), 125I seed and 6 MV x-ray, to 
study the dose response of the TLDs. TLDs were irradiated to 
a dose of 1 mGy using 137Cs, 48 keV, 65 keV, 83 keV, 118 keV 
and 250 keV x-rays, to study the energy response of the TLDs. 
TLDs were irradiated to a dose of 120 MU using 6 MV x-ray 
with different dose rates of 37 MU/min, 75 MU/min, 150 
MU/min, 300 MU/min and 600 MU/min; TLDs were irradiated 
to the same dose using three 125I seeds with different 
activities of 0.739 mCi, 0.675 mCi and 0.559 mCi, and the 
irradiated time were 24 h, 26h 17 min and 31 h 48 min, 
respectively, to study the dose rate effect of TLDs for 6 MV x-
ray and 125I seed. 
Results: 350 TLD2000 TLDs were selected with the sensitivity 
within ±3.0%. The maximum deviations of the repeatability 
were 2.7% and 4.0% for 6 MV x-ray and 125I seed, respectively. 
The dose response of TLDs for 137Cs and 125I seed were linear. 
For 6 MV x-ray, the linear response range were 0.74 Gy-10.0 
Gy, beyond 10.0 Gy the dose response became supralinear 
but proportional to the absorbed dose to TLD. The energy 
response for 48 keV, 65 keV, 83 keV, 118 keV and 250 keV x-
rays, relative to the energy response of 137Cs, were 1.25, 
1.08, 0.99, 0.91 and 0.96, respectively. There were no dose 
rate effects in the dose rate range of 37 MU/min to 600 
MU/min for 6 MV x-ray and 0.66 cGy/h to 0.87 cGy/h for 125I 
seed. 
Conclusions: TLD2000 TLD has good repeatability and linear 
dose response for 137Cs, 125I seed and 6 MV x-ray without dose 
rate effect, but the dose response is energy dependent. 
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Purpose/Objective: The aim of this work was to study the 
characteristics of the ionization chamber array 1000 SRS 
(PTW) for flattening filter (FF) and flattening free filter (FFF) 
beams delivered by a True Beam STx linear accelerator 
(Varian). The array with the octavius 4D phantom was 
evaluated for pretreatment QA of FF and FFF stereotactic 
treatment plans. 
Materials and Methods: The response of the detectors to 
field size, dose linearity, and dose rate were assessed for 6 
and 10 MV FF and 6 and 10 MV FFF. Dosimetric accuracy of 
the detector array was evaluated against measurements 
made using PTW electron diode 60017 (Ediode), PTW 
microDiamond 60019 and PTW semiflex 31010 for field size 
superior to 3x3 cm². Pretreatment QA of FF and FFF 
stereotactic treatment plans were evaluated using a 3D 
gamma function with 2%/2mm tolerance. Stereotacic 
treatment plans were calculated with two treatment 
3rd ESTRO Forum 2015                                                                                                                                         S759 
 
planning systems: Varian's Eclipse for extracranial treatments 
and with Brainlab's iplan for intracranial treatments. 
Results: Output factors of 1000 SRS agreed with semiflex 
measurements for field size between 3x3cm² and 10x10 cm². 
The larger deviations were observed for the 1x1 cm² field 
size: compared to microDiamond, deviations of 1.6%, 2.5%, 
1.7% and 3.3% were observed for 6, 10 MV FF and 6, 10 MV 
FFF respectively. For the 2x2 cm² field size, deviations were 
less than 1.5% for 6 MV FF and 6 MV FFF and 2.5% for 10 MV 
FF and 10 MV FFF. The 1000 SRS showed large dependent 
dose rate response. This effect was about 1% for 6, 10 MV FF 
and increased to 2.5% for 6 MV FFF and 4% for 10 MV FFF. 
Stereotactic treatment plans gave excellent agreement with 
more than 95% of pixels passing 2%/2mm gamma criteria.  
 
Conclusions: The 4D octavius phantom with associated 1000 
SRS ionization chamber array could be used for stereotactic 
pretreatment QA of FF and FFF beams. It is however 
mandatory to calibrate 1000 SRS for a field size and a dose 
rate close to the patient treatment plan. 
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Purpose/Objective: When ArcCHECK (Sun Nuclear Corp., 
Melbourne, FL) is used for Quality Assurance (QA) on helical 
Tomotherapy treatment plans, Tomotherapy measurement 
mode is applied and there is no correction on diode response 
for field size dependency. It is recommended to use a 
standard size 40x5 cm2 of Tomotherapy static beam for 
ArcCHECK absolute dose calibration . Under such dose 
calibration ArcCHECK measurement does not produce good 
result for helical treatment plan with small target (dimension 
< 3 cm) and high modulation factor (>2.5), with gamma 
passing rate (3% dose, 3 mm distance to agreement) normally 
below 85% in absolute dose comparison. During such helical 
treatment, there are fast and frequent movement of small 
number of MLC leaves while the gantry is rotating. It is 
similar to small field irradiation at many different gantry 
angles. Solid state diodes on the ArcCHECK are slightly 
energy dependent and more sensitive to low energy 
component of the treatment beam. As the energy spectrum 
of treatment beam changes for small field size, the 
sensitivity of the diodes changes correspondingly. In this work 
the ArcCHECK measurements were done on 10 helical 
Tomotherapy treatment plans with small target and high 
modulation factor, with ArcCHECK calibrated under standard 
field (40x5 cm2) and small field (2x2cm2) treatment beam 
respectively to demonstrate if it is necessary to do small field 
dose calibration on ArcCHECK for such Tomotherapy 
treatment QA. 
Materials and Methods; 10 helical Tomotherapy treatment 
plans, with small target size (dimension < 3cm) and high 
modulation factor (>2.5), were used in the study. ArcCHECK 
absolute dose calibration was done initially with a standard 
field (40x5 cm2) and 0.057 cc ionization chamber (A1SL, 
Standard Imaging Inc, Middleton, WI). Absolute point dose 
measurements were also done by placing A1SL ionization 
chamber at the centre of the ArcCHECK with PMMA insert. 
After ArcCHECK measurement on these 10 helical treatment 
plans, absolute dose comparisons between the measurement 
and planning calculation were carried out with gamma test 
(3% dose, 3 mm). The measurements were repeated with 
ArcCHECK calibrated under small field 2x2cm2. The 
difference between the responses of the chamber in the 
standard field and small field 2x2cm2 was corrected in small 
field calibration. 
Results: Absolute point dose measurements for all plans 
showed good agreement with planning calculation as the 
differences were all within ± 2%. When standard field size 
(40x5 cm2) calibration was used, the gamma passing rate of 
ArcCHECK measurements were below 85% (Mean=79.5%, 
S.D.=3.3%) for all plans. When small field (2x2cm2) dose 
calibration was used instead, the gamma passing rates for all 
plans were over 90% (Mean=93.7%, S.D.=1.8%). 
Conclusions: Sensitivity of the diode changes for small 
irradiation field. Small field (2x2cm2) dose calibration on 
ArcCHECK should be used instead when measuring helical 
Tomotherapy treatment with small target and high 
modulation factor in order to correct such sensitivity change.  
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Purpose/Objective: Stereotactic radiation therapy 
(SRS/SBRT) require a more comprehensive quality assurance 
(QA) program than 3DCRT and IMRT (or VMAT), especially 
because of its very high-dose gradients. The purpose of this 
study is to test a IBA 3D dosimetry analysis package, COMPASS 
3.0 with MatriXXEvolution ion chamber array, for SRS/SBRT pre-
treatment verification in terms of 3D dose, gamma analysis, 
Target and OAR structures DVH. 
Materials and Methods: Nine treatment plans (SRS/SBRT) 
with different dose fractionations have been selected: 3 
brain cases (2 cases of 21Gy x 1 and one of 15Gy x 1), 3 liver 
cases (15Gy x 3) and 3 lung cases (2 cases of 15 Gy x 3 and 
one of 8 Gy x 4). All measurements, performed with 
COMPASS, were compared with the reference dose 
